Mukka Proteins delivered remarkable financial performance in the June 2026 quarter, with consolidated net profit surging 1142.76% to ₹18.89 crore compared to ₹1.52 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this represents one of the most significant profit growth rates in the company's recent financial history.
The company's revenue momentum was equally impressive, with sales rising 187.97% to ₹474.80 crore in Q1 FY2026 compared to ₹164.88 crore in the same period last year. As reported by Business Standard, this substantial revenue growth demonstrates the company's ability to capitalize on market opportunities and execute its business strategy effectively.
Operating profit margin (OPM) improved to 9.91% in the June 2026 quarter from 8.55% in the corresponding quarter of the previous year. According to the financial data reported by Business Standard, this margin expansion indicates better cost management and operational efficiency during the quarter.
Profit before tax (PBT) increased dramatically by 1060% to ₹27.37 crore in Q1 FY2026 from ₹2.36 crore in the previous year. Additionally, PBDT (Profit Before Depreciation and Tax) rose 472% to ₹32.17 crore compared to ₹5.62 crore in the corresponding quarter of the previous year. These figures, as reported by Business Standard, demonstrate the company's strong operational performance across all profitability metrics.
